These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Can surgical adhesives may cause false positivity in follow-up positron emission tomography after lung cancer resection? Doğan R, Uysal S, Kumbasar U, Köksal D, Ancın B, Tuncel M. Tuberk Toraks; 2021 Mar; 69(1):59-64. PubMed ID: 33853306 [Abstract] [Full Text] [Related]
26. Incidence of Brain Metastases on Follow-up 18F-FDG PET/CT Scans of Non-Small Cell Lung Cancer Patients: Should We Include the Brain? Nia ES, Garland LL, Eshghi N, Nia BB, Avery RJ, Kuo PH. J Nucl Med Technol; 2017 Sep; 45(3):193-197. PubMed ID: 28705927 [Abstract] [Full Text] [Related]
29. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma. Park JW, Jo MK, Lee HM. BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371 [Abstract] [Full Text] [Related]
32. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions. Singnurkar A, Solomon SB, Gönen M, Larson SM, Schöder H. J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787 [Abstract] [Full Text] [Related]
33. PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients. Lim CH, Ahn TR, Moon SH, Cho YS, Choi JY, Kim BT, Lee KH. Eur Radiol; 2019 Apr; 29(4):1903-1911. PubMed ID: 30315418 [Abstract] [Full Text] [Related]
39. Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers. Bayarri-Lara CI, de Miguel Pérez D, Cueto Ladrón de Guevara A, Rodriguez Fernández A, Puche JL, Sánchez-Palencia Ramos A, Ruiz Zafra J, Giraldo Ospina CF, Delgado-Rodríguez M, Expósito Ruiz M, Moyano Rodriguez MJ, Lorente JA, Serrano MJ. Eur J Cardiothorac Surg; 2017 Jul 01; 52(1):55-62. PubMed ID: 28369376 [Abstract] [Full Text] [Related]
40. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Hoopes DJ, Tann M, Fletcher JW, Forquer JA, Lin PF, Lo SS, Timmerman RD, McGarry RC. Lung Cancer; 2007 May 01; 56(2):229-34. PubMed ID: 17353064 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]